Development and validation of a risk prediction model for early-onset hypoglycemia in preterm infants

The model demonstrated promising predictive ability for early-onset hypoglycemia in preterm infants and could potentially serve as a preliminary tool to inform risk stratification strategies. However, its clinical translation requires confirmation through external validation in prospective, multicenter studies before any consideration of widespread implementation.